EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

No sex‐based differences in odds of starting or time to treatment of generalized myasthenia gravis: A single center cohort study

Benjamin Beland iD, Tefani Perera iD, Angela Lee iD, Jamie Greenfield, Lawrence Korngut iD, Gordon Jewett iD

Muscle & Nerve · 2024

DOI: 10.1002/mus.28210 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Muscle & Nerve, 2024. Verfasst von Benjamin Beland und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Myasthenia Gravis, Time-to-Treatment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Females with generalized myasthenia gravis (gMG) report lower quality of life (QoL) and have more severe disease than males. Sex differences in disease characteristics exist, however whether there are sex differences in the treatment of gMG that may contribute to QoL disparities is unknown. Our objective is to determine whether there are sex differences in the treatment of gMG.

Methods

We performed a single‐center retrospective study of people diagnosed with gMG at the University of Calgary between 1997 and 2021. Primary outcome was proportion starting treatment and secondary outcome was time from diagnosis to treatment initiation. Treatments included pyridostigmine, prednisone, steroid sparing therapies (azathioprine, mycophenolate mofetil [MMF], methotrexate [MTX], or tacrolimus), intravenous immunoglobulin (IVIg), plasmapheresis, rituximab, eculizumab, cyclosporine, stem cell transplantation, and thymectomy. Multivariable logistic and Cox proportional hazards regression models were used to examine treatment associations with sex, adjusted for time from onset to diagnosis, age at diagnosis, presence of thymoma, and antibody status.

Results

A total of 179 people with gMG were included (41.9% female). Odds of starting treatment were not statistically associated with sex after adjustment for confounders and correction for multiple testing. Results of the secondary analysis using time to treatment initiation as the outcome were similar.

Discussion

We found no sex differences in odds of starting treatment or time to treatment initiation that might explain previously observed sex‐based differences in QoL. Future work should capture physician and patient treatment preferences that may influence disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisTime-to-TreatmentHumansMaleFemaleMiddle AgedRetrospective StudiesAdultAgedCohort StudiesThymectomyQuality of LifeSex FactorsImmunosuppressive AgentsSex Characteristics

Stichwörter der Autor:innen

myasthenia gravisneuromuscular junctionquality of lifesextreatment

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

ORCID-Profile: Benjamin Beland, Tefani Perera, Angela Lee, Lawrence Korngut, Gordon Jewett

Zitieren

APA

Beland, B., Perera, T., Lee, A., Greenfield, J., Korngut, L., & Jewett, G. (2024). No sex‐based differences in odds of starting or time to treatment of generalized myasthenia gravis: A single center cohort study. Muscle & Nerve. https://doi.org/10.1002/mus.28210

Vancouver

Beland B, Perera T, Lee A, Greenfield J, Korngut L, Jewett G. No sex‐based differences in odds of starting or time to treatment of generalized myasthenia gravis: A single center cohort study. Muscle & Nerve. 2024. doi:10.1002/mus.28210

BibTeX
@article{Beland2024,
  author = {Beland, Benjamin and Perera, Tefani and Lee, Angela and Greenfield, Jamie and Korngut, Lawrence and Jewett, Gordon},
  title = {No sex‐based differences in odds of starting or time to treatment of generalized myasthenia gravis: A single center cohort study},
  journal = {Muscle & Nerve},
  year = {2024},
  doi = {10.1002/mus.28210}
}
Kostenlos starten →